Clinical Trial Update: A Study to Evaluate Efficacy and Safety of Toludesvenlafaxine Hydrochloride Sustained-release Tablets in Generalized Anxiety Disorder. [Phase 3]

View source ↗

Summary

Phase 3 trial investigating toludesvenlafaxine hydrochloride sustained-release tablets for generalized anxiety disorder is currently recruiting to evaluate effi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Generalized Anxiety Disorder

Drugs mentioned

• Toludesvenlafaxine hydrochloride sustained-release tablets (toludesvenlafaxine hydrochloride)

Snippet

Sponsor: Luye Pharma Group Ltd. | Conditions: Generalized Anxiety Disorder | Phase 3 | Status: RECRUITING